IDRx
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today’s precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy.
1
Funding Rounds
$120.0m
Money raised
Overview
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today’s precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy.
- Website:
- Business model: B2B
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company IDRx has raised a total of $120m in funding over 1 rounds.
Key Insights:
- Idrx August 2024 Series B Funding Round: $120m
Idrx August 2024 Series B Funding Round
$120m
Industries
IDRx is active in the following industries: